Next Article in Journal
Biology, Pathophysiological Role, and Clinical Implications of Exosomes: A Critical Appraisal
Next Article in Special Issue
Extracellular Matrix and Fibrocyte Accumulation in BALB/c Mouse Lung upon Transient Overexpression of Oncostatin M
Previous Article in Journal
Targeting Hedgehog Signalling through the Ubiquitylation Process: The Multiple Roles of the HECT-E3 Ligase Itch
Previous Article in Special Issue
Transcriptome-Wide Analysis of Human Chondrocyte Expansion on Synoviocyte Matrix
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessArticle
Cells 2019, 8(2), 97;

Low Molecular Mass Myocardial Hyaluronan in Human Hypertrophic Cardiomyopathy

Cardiology, Heart Centre, Department of Public Health and Clinical Medicine, Umeå University, 901 85 Umeå, Sweden
Department of Cardiology, Oslo University Hospital Rikshospitalet, 0424 Oslo, Norway
Department of Clinical Medicine, UiT, the Arctic University of Norway, 9019 Tromsø, Norway
Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, 0372 Oslo, Norway
Faculty of Medicine, University of Oslo, 0318 Oslo, Norway
Department of Thoracic and Cardiovascular Surgery, Oslo University Hospital Rikshospitalet, 0424 Oslo, Norway
Author to whom correspondence should be addressed.
Received: 13 December 2018 / Revised: 11 January 2019 / Accepted: 23 January 2019 / Published: 29 January 2019
(This article belongs to the Special Issue Extracellular Matrix Remodeling)
Full-Text   |   PDF [3690 KB, uploaded 29 January 2019]   |  


During the development of hypertrophic cardiomyopathy, the heart returns to fetal energy metabolism where cells utilize more glucose instead of fatty acids as a source of energy. Metabolism of glucose can increase synthesis of the extracellular glycosaminoglycan hyaluronan, which has been shown to be involved in the development of cardiac hypertrophy and fibrosis. The aim of this study was to investigate hyaluronan metabolism in cardiac tissue from patients with hypertrophic cardiomyopathy in relation to cardiac growth. NMR and qRT-PCR analysis of human cardiac tissue from hypertrophic cardiomyopathy patients and healthy control hearts showed dysregulated glucose and hyaluronan metabolism in the patients. Gas phase electrophoresis revealed a higher amount of low molecular mass hyaluronan and larger cardiomyocytes in cardiac tissue from patients with hypertrophic cardiomyopathy. Histochemistry showed high concentrations of hyaluronan around individual cardiomyocytes in hearts from hypertrophic cardiomyopathy patients. Experimentally, we could also observe accumulation of low molecular mass hyaluronan in cardiac hypertrophy in a rat model. In conclusion, the development of hypertrophic cardiomyopathy with increased glucose metabolism affected both hyaluronan molecular mass and amount. The process of regulating cardiomyocyte size seems to involve fragmentation of hyaluronan. View Full-Text
Keywords: hypertrophic cardiomyopathy; hyaluronan; metabolomics; GEMMA; glucose hypertrophic cardiomyopathy; hyaluronan; metabolomics; GEMMA; glucose

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Lorén, C.E.; Dahl, C.P.; Do, L.; Almaas, V.M.; Geiran, O.R.; Mörner, S.; Hellman, U. Low Molecular Mass Myocardial Hyaluronan in Human Hypertrophic Cardiomyopathy. Cells 2019, 8, 97.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top